Replies to post #117620 on NanoViricides Inc. (NNVC)

[loanranger]

"The 2016 Disruptive Growth & Healthcare Conference will feature presentations from CEOs, CFOs, COOs and CMOs of life science companies focusing on solutions to unmet medical needs and growth companies with disruptive technologies and business models. Attendees will include over 400 institutional investors, accredited investors, family offices, analysts, registered investment advisors, wealth managers, Source reps and their clients. The panels will cover regenerative medicine, immunotherapy, diagnostics, disruptive innovations and business models, disruptive holding companies, energy – clean tech, technology media & telecom (TMT), and finally a discussion regarding NOLs and rights offerings. The conference is being co-sponsored by several industry firms offering you a unique opportunity to showcase your company. Presently Source has 8 offices, approximately 100 registered representatives, $750 million in assets, 10,000 retail accounts and is a SEC registered investment advisor. The conference is open to all Financial Advisors, Wealth Managers, Family Offices, Sell-Side Analysts, Institutional Investors, Accredited Investors, and Clients. Those non-investment professionals wishing to attend will be asked to pay a fee of $1200."
http://www.meetmax.com/sched/event_35292/~public/conference_home.html?event_id=35292